Dissolution variability: comparison of commercial dosage forms with US Pharmacopeia Lot P Prednisone reference standard tablets--a technical note.
作者信息
Nithyanandan Pallavi, Hauck Walter W, Munoz Jimmy, Deng Gang, Brown William, Manning Ronald G, Wahab Samir
机构信息
United States Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, USA.
出版信息
AAPS PharmSciTech. 2008;9(1):238-42. doi: 10.1208/s12249-008-9034-z. Epub 2008 Feb 8.
Abstract
摘要
相似文献
1
Dissolution variability: comparison of commercial dosage forms with US Pharmacopeia Lot P Prednisone reference standard tablets--a technical note.
AAPS PharmSciTech. 2008;9(1):238-42. doi: 10.1208/s12249-008-9034-z. Epub 2008 Feb 8.
2
Establishing new acceptance limits for dissolution performance verification of USPC apparatus 1 and 2 using USPC prednisone tablets reference standard.
Pharm Res. 2011 Mar;28(3):505-16. doi: 10.1007/s11095-010-0295-3. Epub 2010 Oct 16.
3
The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
Pharm Res. 2008 May;25(5):1100-9. doi: 10.1007/s11095-007-9498-7. Epub 2008 Jan 3.
4
The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.
Pharm Res. 2008 May;25(5):1110-5. doi: 10.1007/s11095-007-9482-2. Epub 2008 Jan 3.
5
Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
J Pharm Sci. 1984 May;73(5):670-6. doi: 10.1002/jps.2600730520.
6
Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
J Pharm Sci. 2013 Aug;102(8):2718-29. doi: 10.1002/jps.23651. Epub 2013 Jul 16.
7
Vibration effects of lab equipment on dissolution testing with USP paddle method.
J Pharm Sci. 2010 Jan;99(1):403-12. doi: 10.1002/jps.21847.
8
Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
J Pharm Biomed Anal. 2003 Apr 10;31(6):1129-43. doi: 10.1016/s0731-7085(02)00732-x.
9
Equivalence studies for complex active ingredients and dosage forms.
AAPS J. 2005 Nov 17;7(4):E786-812. doi: 10.1208/aapsj070477.
10
The development of USP dissolution and drug release standards.
Pharm Res. 1990 Oct;7(10):983-7. doi: 10.1023/a:1015922629207.
引用本文的文献
1
Response to the Commentary from A Dissolution Working Group on "The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method": Clarifications and Opportunities for Engagement.
AAPS J. 2025 Jul 16;27(5):120. doi: 10.1208/s12248-025-01107-9.
2
Effects of Glass Bead Size on Dissolution Profiles in Flow-through Dissolution Systems (USP 4).
AAPS PharmSciTech. 2024 Oct 22;25(8):251. doi: 10.1208/s12249-024-02972-x.
本文引用的文献
1
The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.
Pharm Res. 2008 May;25(5):1110-5. doi: 10.1007/s11095-007-9482-2. Epub 2008 Jan 3.
2
The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
Pharm Res. 2008 May;25(5):1100-9. doi: 10.1007/s11095-007-9498-7. Epub 2008 Jan 3.
3
Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations.
AAPS PharmSciTech. 2000 Jun 17;1(2):E14. doi: 10.1208/pt010214.
4
Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
Eur J Pharm Sci. 1999 Feb;7(3):249-58. doi: 10.1016/s0928-0987(98)00034-7.
5
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.
Pharm Dev Technol. 1998 Nov;3(4):535-47. doi: 10.3109/10837459809028636.
6
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
Pharm Dev Technol. 1998 Nov;3(4):443-52. doi: 10.3109/10837459809028625.
7
The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
Pharm Dev Technol. 1996 Dec;1(4):343-55. doi: 10.3109/10837459609031429.
Zotero 插件